fluorobenzenes has been researched along with Osteoporosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Debanne, SM; Erlandson, KM; Jiang, Y; McComsey, GA | 1 |
Capecchi, PL; Capperucci, C; Ferrata, P; Frediani, B; Galeazzi, M; Laghi-Pasini, F; Lazzerini, PE; Niccolini, S; Spreafico, A | 1 |
Jadhav, SB; Jain, GK | 1 |
1 review(s) available for fluorobenzenes and Osteoporosis
Article | Year |
---|---|
Statins and osteoporosis: new role for old drugs.
Topics: Animals; Atorvastatin; Bone and Bones; Clinical Trials as Topic; Drug Delivery Systems; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Fractures, Bone; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Liver; Lovastatin; Osteogenesis; Osteoporosis; Pharmacokinetics; Pravastatin; Pyridines; Pyrimidines; Pyrroles; Quinolines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2006 |
1 trial(s) available for fluorobenzenes and Osteoporosis
Article | Year |
---|---|
Effects of randomized rosuvastatin compared with placebo on bone and body composition among HIV-infected adults.
Topics: Absorptiometry, Photon; Adult; Biomarkers; Body Composition; Bone Density; Cardiovascular Diseases; Female; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Osteoporosis; Pyrimidines; Receptors, Tumor Necrosis Factor, Type I; Regression Analysis; Risk Factors; Rosuvastatin Calcium; Sulfonamides | 2015 |
1 other study(ies) available for fluorobenzenes and Osteoporosis
Article | Year |
---|---|
Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells.
Topics: Aged; Bone Resorption; Cell Proliferation; Cell Survival; Cells, Cultured; Culture Media; Diterpenes; Farnesol; Femur Head; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Interleukin-1beta; Interleukin-6; Mevalonic Acid; Middle Aged; Osteoblasts; Osteoporosis; Osteoprotegerin; Pyrimidines; RNA, Messenger; Rosuvastatin Calcium; Sulfonamides; Terpenes | 2013 |